GTBP (STOCKS)
GT Biopharma Inc. Common Stock
$7.360000
+1.150000 (+18.52%)
Prev close: $6.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael Breen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15.19M
- Employees
- 1
- P/E (TTM)
- -0.07
- P/B (TTM)
- 3.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-3.00 | $-2.04 | -0.9600 | -47.06% |
|
Mar 2026 (Q1)
|
$-2.75 | $-2.04 | -0.7100 | -34.80% |
|
Dec 2025 (Q4)
|
$-4.84 | $-0.22 | -4.6156 | -2,056.86% |
|
Sep 2025 (Q3)
|
$-0.79 | $-0.39 | -0.4024 | -103.82% |